How long did recruitment of first patient take?
hoping other Aussie biotech aren’t too far behind.
- Forums
- ASX - By Stock
- CU6
- Ann: First patient treated in the Phase II of the SECuRE trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
2.69%
!
$2.29

Ann: First patient treated in the Phase II of the SECuRE trial, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
0.060(2.69%) |
Mkt cap ! $739.1M |
Open | High | Low | Value | Volume |
$2.30 | $2.37 | $2.21 | $4.804M | 2.088M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 2972 | $2.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.30 | 6522 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 2972 | 2.290 |
11 | 35508 | 2.280 |
10 | 60841 | 2.270 |
9 | 55107 | 2.260 |
8 | 25266 | 2.250 |
Price($) | Vol. | No. |
---|---|---|
2.300 | 6243 | 16 |
2.310 | 16598 | 26 |
2.320 | 19587 | 19 |
2.330 | 20491 | 14 |
2.340 | 8701 | 6 |
Last trade - 13.47pm 17/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online